Thomas Pfisterer - 15 May 2025 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Reporting relationship: Other*
Issuer ticker: ADCT
Reported as of: 15 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 May 2025, 15:35:33 UTC
Prior SEC filing: 18 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Thomas Pfisterer

Key filing fact

Thomas Pfisterer filed Form 4 for ADC Therapeutics SA (ADCT) on 19 May 2025.

Key facts

This page summarizes Thomas Pfisterer's Form 4 filing for ADC Therapeutics SA (ADCT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2025, 15:35.

Change

Previous filing in this sequence was filed on 18 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001824238 Primary reporting owner

Pfisterer Thomas

Relationship: Other*
Address: SUURSTOFFI 13A, ROTKREUZ, SWITZERLAND
Signature: /s/ Thomas Pfisterer
Signature date: 15 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADCT transaction

Common Shares

Other

Transaction value
Shares: -451,856
Change %: -72%
Price
Shares after: 173,899
Date: 15 May 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

In addition to the 173,899 shares still owned by Thomas Pfisterer, he previously held 451,856 shares directly or indirectly via HPWH MH AG ("MH") and HPWH TH AG ("HPWH") but following stepping down from the Board of Directors of MH and HPWH transferred ownership by way of an intragroup sale to Dr. Hans-Peter Wild.